Increases in Inhaled Steroids Don’t Prevent Asthma Flare-Ups
Researchers have found that temporarily increasing the dosage of inhaled steroids when asthma symptoms begin to worsen does not effectively prevent severe flare-ups and may be associated with slowing a child’s growth.
Monoclonal Antibodies Crucial To Fighting Emerging Infectious Diseases
Monoclonal antibodies (mAbs)—preparations of a specific type of antibody designed to bind to a single target—have shown promise in the fight against cancer and autoimmune diseases.
Antibody Treatment May Target Viral Reservoir
After receiving a course of antiretroviral therapy for their HIV-like infection, approximately half of a group of monkeys infused with a broadly neutralizing antibody to HIV combined with an immune stimulatory compound suppressed the virus for 6 months without additional treatment, according to scientists supported in part by NIAID.
Scientists Show How the Brain May Be Wired for Drinking Fluids
Scientists have uncovered a high-resolution map of the wiring inside the mouse brain’s thirst center. With these blueprints, they could trick mice into becoming light or heavy water drinkers.
The Brain’s Internal Clock Continually Takes Its Temperature
Circuits in the brain act as an internal clock to tell us it is time to sleep and to control how long we then stay asleep.
Clinical Trial Testing Topical Cream Plus Influenza Vaccine in Progress
A phase 1 clinical trial examining whether a topical cream can enhance the immune response conferred by a “pre-pandemic” influenza vaccine is underway at Baylor College of Medicine in Houston.
Genetics and Pollution Drive Severity of Asthma Symptoms
Asthma patients with a specific genetic profile exhibit more intense symptoms following exposure to traffic pollution, according to researchers at NIEHS and collaborators.
Stress Wracks Worm Nerves, Leaving Lasting Memories
Scientists stunted the puberty of male worms by starving them before they underwent sexual maturation.
Researchers Find Potential New Gene Therapy for Blinding Disease
Scientists funded by the National Eye Institute report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP).